EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy

Adina Stoian iD, Carmen Muntean iD, Dragoș-Florin Babă iD, Andrei Manea iD, Lóránd Dénes iD, Zsuzsánna Simon-Szabó iD, Irina Bianca Kosovski iD, Enikő Nemes-Nagy, Florina Ioana Gliga iD, Mircea Stoian iD

International Journal of Molecular Sciences · 27.09.2024 · 25 (19) · 10395

DOI: 10.3390/ijms251910395 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.09.2024. Verfasst von Adina Stoian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romani…. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Biomarkers, Inflammation. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitatea de Medicină, Farmacie, Științe și Tehnologie "George Emil Palade" din Târgu Mureș, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is an increasing prevalence of diabetes mellitus (DM), particularly type 2 DM (T2DM), and its associated complications. T2DM is linked to insulin resistance, chronic inflammation, and oxidative stress, which can lead to both macrovascular and microvascular complications, including peripheral diabetic neuropathy (PDN). Inflammatory processes play a key role in the development and progression of T2DM and its complications, with specific markers like C-reactive protein (CRP), interleukins (ILs), and tumor necrosis factor (TNF)-α being associated with increased risk. Other key inflammatory markers such as nuclear factor kappa B (NF-κB) are activated under hyperglycemic and oxidative stress conditions and contribute to the aggravation of PDN by regulating inflammatory gene expression and enhancing endothelial dysfunction. Other important roles in the inflammatory processes are played by Toll-like receptors (TLRs), caveolin 1 (CAV1), and monocyte chemoattractant protein 1 (MCP1). There is a relationship between vitamin D deficiency and PDN, highlighting the critical role of vitamin D in regulating inflammation and immune responses. The involvement of macrophages in PDN is also suspected, emphasizing their role in chronic inflammation and nerve damage in diabetic patients. Vitamin D supplementation has been found to reduce neuropathy severity, decrease inflammatory markers, and improve glycemic control. These findings suggest that addressing vitamin D deficiency could offer therapeutic benefits for PDN. These molecular pathways are critical in understanding the pathogenesis of DM complications and may offer potential biomarkers or therapeutic targets including anti-inflammatory treatments, vitamin D supplementation, macrophage phenotype modulation, and lifestyle modifications, aimed at reducing inflammation and preventing PDN. Ongoing and more extensive clinical trials with the aim of investigating anti-inflammatory agents, TNF-α inhibitors, and antioxidants are needed to advance deeper into the understanding and treatment of painful diabetic neuropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesBiomarkersInflammationHumansDiabetes Mellitus, Type 2Oxidative StressAnimals

Stichwörter der Autor:innen

Toll-like receptor 4 (TLR4)caveolin 1diabetic neuropathyinflammationtype 2 diabetes mellitus (T2DM)vitamin D

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pathophysiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
  • Department of Pediatrics 1, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
  • Emergency Institute for Cardiovascular Diseases and Transplantation, 540142 Targu Mures, Romania.
  • Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
  • Department of Radiology, Mureș County Emergency Hospital, 540136 Targu Mures, Romania.
  • Department of Anatomy and Embryology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.

ORCID-Profile: Adina Stoian, Carmen Muntean, Dragoș-Florin Babă, Andrei Manea, Lóránd Dénes, Zsuzsánna Simon-Szabó, Irina Bianca Kosovski, Florina Ioana Gliga, Mircea Stoian

Förderung

  • Universitatea de Medicină, Farmacie, Științe și Tehnologie "George Emil Palade" din Târgu Mureș
  • George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Research

Zitieren

APA

Stoian, A., Muntean, C., Babă, D. F., Manea, A., Dénes, L., Simon-Szabó, Z., Kosovski, I. B., Nemes-Nagy, E., Gliga, F. I., & Stoian, M. (2024). Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy. International Journal of Molecular Sciences, 25(19), 10395. https://doi.org/10.3390/ijms251910395

Vancouver

Stoian A, Muntean C, Babă DF, Manea A, Dénes L, Simon-Szabó Z, et al. Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy. International Journal of Molecular Sciences. 2024;25(19):10395. doi:10.3390/ijms251910395

BibTeX
@article{Stoian2024,
  author = {Stoian, Adina and Muntean, Carmen and Babă, Dragoș-Florin and Manea, Andrei and Dénes, Lóránd and Simon-Szabó, Zsuzsánna and Kosovski, Irina Bianca and Nemes-Nagy, Enikő and Gliga, Florina Ioana and Stoian, Mircea},
  title = {Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {19},
  pages = {10395},
  doi = {10.3390/ijms251910395}
}
Kostenlos starten →